ARX Stock Analysis: Buy, Sell, or Hold?
ARX - Accelerant Holdings
$19.59
0.02 (0.10%)
▲
5d:
+0.05%
30d:
+42.27%
90d:
+15.3%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ARX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ARX is 12.5% above its trading range ($17.42). Market expects 9.8% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ARX is 12.5% above its trading range ($17.42). Market expects 9.8% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.60
Based on 4.6% avg growth
INTRINSIC VALUE TODAY
$11.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARX is currently trading at $19.59, which is considered extended relative to its 30-day fair value range of $11.64 to $17.42. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.8) compared to its historical average (15.8). At these levels, the market is pricing in 9.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ARX is showing sideways momentum. The price is approaching resistance at $19.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $23.50 (+20.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARX is showing sideways momentum. The price is approaching resistance at $19.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $23.50 (+20.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.64 -
$17.42
Company Quality Score
33/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
11.9%
All Signals
- BEARISH: Price significantly overextended (+12.5% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: Trading below Wall St target ($23.50)
- NEUTRAL: PE elevated vs history but 9.8% growth expectation is conservative given 800% recent growth
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.64 -
$17.42
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$11.89
Resistance Level
$19.66
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.84
Wall Street Target
$23.50
(+20.0%)
Revenue Growth (YoY)
57.2%
Earnings Growth (YoY)
800.0%
Profit Margin
-127.5%
Valuation Premium vs History
+9.8% premium
PE vs Historical
20.8 vs 15.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.8%
(market-implied from PE analysis)
1-Year Target
$21.51
(+10%)
2-Year Target
$23.62
(+21%)
3-Year Target
$25.93
(+32%)
3-Yr Target (if PE normalizes)
(PE: 21→16)
PE COMPRESSION
$19.66
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.8, Growth: 5.2%)
$22.79
(+16%)
Base:
(SPY PE: 20.1, Growth: 5.2%)
$21.95
(+12%)
Bear:
(PE: 15.8, Growth: 5.2%)
$17.28
(-12%)
Share & Embed Analysis
Last updated: August 24, 2026 7:00 AM ET
Data refreshes hourly during market hours. Next update: 8:00 AM
Data refreshes hourly during market hours. Next update: 8:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jay Michael Green
SELL
50000 shares
2026-03-23
Top Rated Insurance Brokers Stocks
Top-rated stocks in Insurance Brokers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AJG
Arthur J Gallagher & Co |
BUY
22 analysts |
$292 | 41 HOLD |
|
AON
Aon PLC |
HOLD
20 analysts |
$404 | 64 BUY |
|
WTW
Willis Towers Watson PLC |
STRONG BUY
18 analysts |
$380 | 45 HOLD |
|
MMC
Marsh & McLennan Compani… |
SELL
20 analysts |
$211 | 49 HOLD |
|
GOCO
GoHealth Inc. |
STRONG BUY
5 analysts |
$5 | 52 HOLD |